140 results
Page 4 of 7
8-K
EX-5.1
a8y9uu 2zvuxoxkwrg4
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
kdo y4qfktvi4ix8l0
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.2
s3pj0jy36kuni48 iy
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
xfqqle nqof0qk
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
F-6EF
ydlrzgfc8040x 9zuh
30 Aug 19
Automatic registration for ADRs (foreign)
1:06pm
F-6EF
EX-99
97h950npq3e
30 Aug 19
Automatic registration for ADRs (foreign)
1:06pm
S-8
EX-5.1
hftazg0n 9x
30 Aug 19
Registration of securities for employees
12:30pm
S-8
tk248 2bd4lnmf9nhra
30 Aug 19
Registration of securities for employees
12:30pm
8-K
EX-10.1
ruueca
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-10.1
hhff gmv3qe
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.4
mupewe9h6jrxkeezwhfd
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.1
7cyotl
27 Jun 19
Departure of Directors or Certain Officers
8:08am